XML 18 R2.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Income - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]      
Net sales $ 1,074.4 $ 1,022.8 $ 1,041.3
Cost of products sold 766.1 732.8 762.8
Gross profit 308.3 290.0 278.5
Selling expense 36.9 33.7 35.7
Research expense 13.8 13.5 15.2
General expense 116.9 105.1 90.9
Total nonmanufacturing expenses 167.6 152.3 141.8
Restructuring and impairment expense 11.9 3.7 1.7
Operating profit 128.8 134.0 135.0
Interest expense 30.5 36.1 28.2
Other (expense) income, net (1.0) (1.0) 10.0
Income from continuing operations before income taxes and income from equity affiliates 97.3 96.9 116.8
Provision for income taxes 18.4 15.2 10.7
Income (Loss) from equity affiliates, net of income taxes 4.9 4.1 (11.3)
Income from continuing operations 83.8 85.8 94.8
Loss from discontinued operations 0.0 0.0 (0.3)
Net income $ 83.8 $ 85.8 $ 94.5
Net income (loss) per share - basic:      
Income per share from continuing operations (in dollars per share) $ 2.68 $ 2.78 $ 3.08
Loss per share from discontinued operations (in dollars per share) 0 0 (0.01)
Net income per share - basic (in dollars per share) 2.68 2.78 3.07
Net income (loss) per share – diluted:      
Income per share from continuing operations (in dollars per share) 2.66 2.76 3.07
Loss per share from discontinued operations (in dollars per share) 0 0 (0.01)
Net income per share - diluted (in dollars per share) $ 2.66 $ 2.76 $ 3.06
Weighted average shares outstanding:      
Basic (in shares) 30,832,700 30,652,200 30,551,300
Diluted (in shares) 31,104,200 30,838,300 30,692,900